1. Elevated phosphorylation of EGFR in NSCLC due to mutations in PTPRH
    Matthew R. Swiatnicki et al, 2022, PLOS Genetics CrossRef
  2. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma
    Aifeng Chen et al, 2021, Computational and Mathematical Methods in Medicine CrossRef
  3. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation
    Qunhao Zheng et al, 2021, BMC Cancer CrossRef
  4. Uncovering Driver DNA Methylation Events in Nonsmoking Early Stage Lung Adenocarcinoma
    Xindong Zhang et al, 2016, BioMed Research International CrossRef
  5. Genome‐scale analysis to identify prognostic markers and predict the survival of lung adenocarcinoma
    Yan‐Yan Li et al, 2018, Journal of Cellular Biochemistry CrossRef
  6. Crystal structure of the catalytic domain of human RPTPH
    Myeongbin Kim et al, 2022, Acta Crystallographica Section F Structural Biology Communications CrossRef
  7. Protein tyrosine phosphatases: promising targets in pancreatic ductal adenocarcinoma
    Mariana Tannús Ruckert et al, 2019, Cellular and Molecular Life Sciences CrossRef
  8. Recent advances in epigenomics in NSCLC: real-time detection and therapeutic implications
    Antonello Di Paolo et al, 2016, Epigenomics CrossRef
  9. FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma
    Yilin Yu et al, 2021, Aging CrossRef
  10. PTPRH promotes the progression of non-small cell lung cancer via glycolysis mediated by the PI3K/AKT/mTOR signaling pathway
    Shu Wang et al, 2023, Journal of Translational Medicine CrossRef
  11. Molecular Typing Based on Oxidative Stress Genes and Establishment of Prognostic Characteristics of 7 Genes in Lung Adenocarcinoma
    Jing Tu et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
  12. Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer
    Laura Boyero et al, 2023, Cancers CrossRef
  13. CANT1 serves as a potential prognostic factor for lung adenocarcinoma and promotes cell proliferation and invasion in vitro
    Qiwei Yao et al, 2022, BMC Cancer CrossRef
  14. PTPRH
    Yoji Murata et al, 2018, Encyclopedia of Signaling Molecules CrossRef
  15. Paired Expression Analysis of Tumor Cell Surface Antigens
    Rimas J. Orentas et al, 2017, Frontiers in Oncology CrossRef
  16. Molecular profiling of mucinous epithelial ovarian cancer by weighted gene co-expression network analysis
    Gui Hong Zhang et al, 2019, Gene CrossRef
  17. Stepping out of the shadows: Oncogenic and tumor-promoting protein tyrosine phosphatases
    Ari Elson, 2018, The International Journal of Biochemistry & Cell Biology CrossRef
  18. Identification of novel regulators of STAT3 activity
    Elina Parri et al, 2020, PLOS ONE CrossRef
  19. PTPRH
    Yoji Murata et al, 2017, Encyclopedia of Signaling Molecules CrossRef
  20. A Systematic Review of Progress toward Unlocking the Power of Epigenetics in NSCLC: Latest Updates and Perspectives
    Anetta Sulewska et al, 2023, Cells CrossRef
  21. Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma
    Yang Zhai et al, 2021, BMC Cancer CrossRef
  22. PTPRH Alleviates Airway Obstruction and Th2 Inflammation in Asthma as a Protective Factor
    Feng-jia Chen et al, 2022, Journal of Asthma and Allergy CrossRef